Rokit Healthcare KRX:376900KOSDAQ

로킷헬스케어 · Korean news coverage and regulatory filings, organized.

Articles, 24h14
Articles, 7 days50
DART filings, 7 days0
Articles tracked91since Sep 11

In Q2 2026, Rokit Healthcare reported revenue of ₩8.2bn, up 36.6% year on year, and an operating loss of ₩13.5bn. Rokit Healthcare (로킷헬스케어) appeared in 50 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 29 with 15 articles. The most common catalyst was clinical & approvals (7). It was most often mentioned alongside 글로벌테크놀로지.

Filing signals Swung to loss Screener

Rokit Healthcare quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩8.2bn+36.6%−₩13.5bn
margin −163.7%
−₩9.3bn
Q1 2026₩8.1bn+118.1%−₩2.4bn
margin −29.2%
−₩1.9bn
Q4 2025 derived₩9.6bn+161.5%₩600m
margin 6.3%
−₩307m
Q3 2025₩7.0bn+173.7%₩78m
margin 1.1%
−₩1.2bn
Q2 2025₩6.0bn+66.4%₩22m
margin 0.4%
−₩980m
Q1 2025₩3.7bn+12.3%−₩247m
margin −6.7%
−₩352m
Q4 2024 derived₩3.7bn-1.0%−₩2.0bn
margin −54.1%
−₩4.9bn
Q3 2024₩2.5bn-23.8%−₩1.9bn
margin −75.5%
−₩1.7bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Rokit Healthcare top stories 2 weeks, by number of outlets

  1. 1
  2. 2
    로킷헬스케어, 유럽 CE MDR 연골 결손 적응증 추가 신청
    4 outlets · 4 articlesFirst report Oct 29 09:08 바이오타임즈
  3. 3
  4. 4
    로킷헬스케어, 하버드 공동연구서 '신장 기능 보존' 확인…美 신장학회 발표 '입증'
    2 outlets · 2 articlesFirst report Oct 27 08:44 프라임경제Partnership
  5. 5
    로킷헬스케어·로킷제노믹스, BIX 2026서 재생의학·정밀 분석 기술 소개
    2 outlets · 2 articlesFirst report Oct 28 13:09 메디컬투데이
  6. 6
    로킷헬스케어, BIX 2026서 AI 장기재생·유전체 분석 기술 선보여
    2 outlets · 2 articlesFirst report Oct 28 16:29 뉴스1

Latest Rokit Healthcare news Korean headlines